TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Jun 2024)
What this means for you
Registered since 04 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87227314
- Registration number
- 5623246
- Mark type
- Design + words
- Filed
- 04 Nov 2016
- Published for opposition
- 03 Oct 2017
- Registered
- 04 Dec 2018
- Attorney of record
- Jack Wessel
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness on the prevention of HIV infection
- Class 044 — Medical, beauty and agricultural services: Medical services, namely, providing information regarding the prevention of HIV infection
Owner
- Gilead Sciences, Inc., Foster City, CA, US
- Gilead Sciences, Inc., Foster City, CA, US
- Gilead Sciences, Inc., Foster City, CA, US
Prior registrations
Prosecution history
- 12 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Jun 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 12 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Dec 2023 — TEAS SECTION 8 & 15 RECEIVED
- 04 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Oct 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Oct 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Oct 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Oct 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 01 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Oct 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Oct 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE